Phathom Pharmaceuticals, Inc.
PHAT
Revenue
7.32M
▲5.41M▲283.05%
3 Months ChangeAssets
319.38M
▼-37.12M▼-10.41%
3 Months ChangeLiabilities
553.21M
▲48.20M▲9.55%
3 Months ChangeFree Cash Flow
-69.06M
▼-29.18M▼-73.16%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-19
Form 8-K
ID: 0001193125-24-202879
2024-08-08
Form 10-Q
ID: 0000950170-24-093885
2024-08-08
Form 8-K
ID: 0001193125-24-196506
2024-07-18
Form 8-K
ID: 0001193125-24-180750
2024-05-24
Form 8-K
ID: 0001193125-24-147017
2024-05-09
Form 10-Q
ID: 0000950170-24-056888
2024-05-09
Form 8-K
ID: 0001193125-24-134793
2024-03-07
Form 8-K
ID: 0001193125-24-061512
2024-02-13
Form 8-K
ID: 0001193125-24-032946
2023-12-15
Form 8-K
ID: 0001193125-23-296630